Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02763150 · ClinicalTrials.gov registry record · NA

Pre-pregnancy Lifestyle Intervention to Prevent the Recurrence of Gestational Diabetes in Overweight and Obese Women

A NA study of Gestational Diabetes Mellitus, sponsored by California Polytechnic State University-San Luis Obispo.

Completed
Registry status
NA
Development phase
199
Enrollment target
2
Study locations

NCT02763150: Completed NA study of Gestational Diabetes Mellitus, sponsored by California Polytechnic State University-San Luis Obispo.

NCT02763150 is a NA study of Gestational Diabetes Mellitus that has completed, run by California Polytechnic State University-San Luis Obispo. The registered enrollment target is 199 participants, below the 407-participant average among 16 other Gestational Diabetes Mellitus trials with a reported enrollment target (51% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02763150, a NA study of Gestational Diabetes Mellitus, has completed, sponsored by California Polytechnic State University-San Luis Obispo.

COMPLETED
Registry status
NA
Development phase
199 participants
Enrollment target
2
Study locations

Study Summary

The overall purpose of this study is to determine the efficacy of a pre-pregnancy lifestyle intervention to reduce the recurrence of gestational diabetes mellitus in multiethnic women with overweight or obesity.

Interventions

  • OTHER Health Promotion
  • BEHAVIORAL Lifestyle intervention

Study Locations (2)

California

  • California Polytechnic State University - San Luis Obispo

Rhode Island

  • Miriam Hospital - Providence

Trial Details

FieldValue
Enrollment Target 199 participants
Start Date 2017-12-15
Est. Completion 2022-07-29
Phase NA

What the finished NCT02763150 record still lists

NCT02763150 is an interventional study that assigns participants to a tested intervention. The registered 199 participants enrollment target is mid-sized for trials with a published cap, below the 407-participant average among 16 other Gestational Diabetes Mellitus trials with a reported enrollment target (51% lower).

The record links to 1 condition, with Gestational Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Health Promotion is the first listed.

NCT02763150 reports a single indexed study location in California, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT02763150 about?

NCT02763150 is a clinical study titled "Pre-pregnancy Lifestyle Intervention to Prevent the Recurrence of Gestational Diabetes in Overweight and Obese Women". The overall purpose of this study is to determine the efficacy of a pre-pregnancy lifestyle intervention to reduce the recurrence of gestational diabetes mellitus in multiethnic women with overweight or obesity.

What is the current status of trial NCT02763150?

This trial is currently completed. It is a NA study. The enrollment target is 199 participants. The study started on 2017-12-15. Estimated completion is 2022-07-29.

What conditions does trial NCT02763150 study?

This clinical trial studies the following conditions: Gestational Diabetes Mellitus.

What interventions are being tested in trial NCT02763150?

The interventions under investigation include: Health Promotion (OTHER), Lifestyle intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02763150?

This trial is sponsored by California Polytechnic State University-San Luis Obispo, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02763150 being conducted?

This trial has 2 study locations across California, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gestational Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02763150's enrollment target sits among peer trials

199 9th of 16 higher than 8 of 16 other Gestational Diabetes Mellitus trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Gestational Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04312126 · 199 participants

    The Beneficial Effects of Naps on Motor Learning

  • NCT04951622 · 199 participants · Phase 3

    A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

  • NCT06474533 · 199 participants

    Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02763150, the US trial registry maintained by the National Library of Medicine. NCT02763150 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.